20.35
                                            Arcus Biosciences Inc Aktie (RCUS) Neueste Nachrichten
Latham & Watkins Advises Arcus Biosciences in US$250 Million Public Offering of Common Stock - Legal Desire Media and Insights
Arcus Biosciences Completes Successful Stock Offering - TipRanks
Arcus Biosciences Completes Public Offering of Common Stock - TradingView
Is Arcus Biosciences Inc. stock a buy on dipsJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Automated trading signals detected on Arcus Biosciences Inc.Trade Volume Report & Consistent Profit Focused Trading Strategies - newser.com
Mizuho Raises Price Target on Arcus Biosciences to $47 From $45, Keeps Outperform Rating - MarketScreener
Why Arcus Biosciences Inc. stock is rated strong buyTrade Exit Summary & Verified Stock Trade Ideas - newser.com
What is the fair value estimate for Arcus Biosciences Inc. stock in 2025Trade Analysis Report & Expert-Curated Trade Recommendations - newser.com
Visual analytics tools that track Arcus Biosciences Inc. performanceBuy Signal & Weekly Breakout Watchlists - newser.com
Does Arcus Biosciences Inc. show high probability of reboundGap Down & Free AI Powered Buy and Sell Recommendations - newser.com
Arcus Biosciences, Inc. (RCUS) Stock Forecasts - Yahoo! Finance Canada
Price action breakdown for Arcus Biosciences Inc.2025 Top Decliners & AI Driven Price Predictions - newser.com
What dividend safety score for Arcus Biosciences Inc. stockJuly 2025 Market Mood & Weekly High Potential Stock Alerts - newser.com
Risk adjusted return profile for Arcus Biosciences Inc. analyzedWeekly Investment Summary & AI Forecasted Entry and Exit Points - newser.com
Should you hold or exit Arcus Biosciences Inc. nowJuly 2025 Market Mood & Low Risk Investment Opportunities - newser.com
Why Arcus Biosciences Inc. stock appears on watchlistsQuarterly Trade Summary & Verified Entry Point Signals - newser.com
How moving averages guide Arcus Biosciences Inc. trading2025 Big Picture & Breakout Confirmation Trade Signals - newser.com
Using AI based signals to follow Arcus Biosciences Inc.2025 EndofYear Setup & Risk Managed Investment Signals - newser.com
Reversal indicators forming on Arcus Biosciences Inc. stockJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com
Arcus Biosciences announces launch of public offering - MSN
Arcus Biosciences prices $250M offering - MSN
Arcus Biosciences (NYSE:RCUS) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
Analyzing recovery setups for Arcus Biosciences Inc. investorsWeekly Investment Recap & High Accuracy Trade Signal Alerts - newser.com
Arcus Biosciences (NYSE:RCUS) Shares Gap Down on Insider Selling - MarketBeat
Arcus Biosciences, Inc. (NYSE:RCUS) Just Reported, And Analysts Assigned A US$29.60 Price Target - simplywall.st
Arcus Biosciences, Inc. (NYSE:RCUS) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
FY2025 EPS Estimates for RCUS Increased by Analyst - MarketBeat
Wedbush Increases Earnings Estimates for Arcus Biosciences - MarketBeat
HC Wainwright Has Positive Forecast for RCUS FY2025 Earnings - MarketBeat
Arcus Biosciences (NYSE:RCUS) President Juan Jaen Sells 19,019 Shares - MarketBeat
Insider Selling: Arcus Biosciences (NYSE:RCUS) President Sells 77,840 Shares of Stock - MarketBeat
Arcus Biosciences stock falls after pricing $250 million public offering By Investing.com - Investing.com Nigeria
Arcus Biosciences launches public offering of common stock By Investing.com - Investing.com Australia
Arcus Biosciences stock falls after pricing $250 million public offering - Investing.com
Analysts Offer Insights on Healthcare Companies: MiMedx Group (MDXG), TransMedics Group (TMDX) and Arcus Biosciences (RCUS) - The Globe and Mail
Arcus Biosciences (RCUS) Announces Pricing Details for Recent Of - GuruFocus
Arcus Biosciences falls after $250 mln stock sale - TradingView
Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Beats Revenue Estimates - MSN
Is Arcus Biosciences Inc. stock safe for risk averse investorsJuly 2025 Fed Impact & High Accuracy Investment Signals - newser.com
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):